Title Date
PD-L1 22C3 IHC pharmDx is now available in EuropeAug 03, 2016
Dako Announces Expanded Use of PD-L1 Diagnostic Test in EuropeMay 12, 2016
Agilent Technologies Statement – the Blueprint ProjectApr 27, 2016
Agilent Announces Availability of New Lung Cancer Test in EuropeApr 06, 2016
Agilent Publishes Overview of Best Practices for Breast Cancer DiagnosisMar 14, 2016
Agilent Technologies to Sponsor USCAP 2016Mar 09, 2016
Dako Announces Expanded FDA Approval of Complementary Diagnostic Test to Include MelanomaJan 25, 2016
Dako Announces FDA Approval of New Test for Lung Cancer PatientsOct 12, 2015
Dako Announces FDA Approval of New Companion Diagnostic for Lung CancerOct 05, 2015
Resolution to U.S. FDA Warning Letter for Dako DenmarkApr 22, 2015
Dako announces expanded collaboration with Amgen within companion diagnosticsMar 24, 2015
Dako and ONO PHARMACEUTICAL CO., LTD. announce collaboration on development of PD-L1 companion diagnostic testFeb 16, 2015
Dako and Cell Signaling Technology announce partnership within companion diagnosticsJan 12, 2015
Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in EuropeSep 01, 2014
Dako Sponsors European Pathology Congress for Second Straight YearAug 29, 2014
Dako Sponsors Largest Histology Congress for 34th Year in a RowAug 25, 2014
New White Paper by ProPath Supports Superiority of Dako’s HER2 IQFISH pharmDxTM KitJul 07, 2014
Dako partners with Euro Diagnostica on Chromogranin A ELISA KitJun 02, 2014
Dako and U.S.-based Merck & Co. to collaborate on companion diagnostic test for analysis of tumor PD-L1 levelsMay 30, 2014
Dako, an Agilent Technologies Company, Launches Two Ready-to-Use Antibodies for Cancer DiagnosisMay 02, 2014
Dako Collaborates on Review of Immunohistochemistry’s Impact on Prostate DiagnosticsMar 05, 2014
Dako White Paper Outlines High-Quality Staining Enabled by Its New Immunohistochemical Staining PrincipleMar 04, 2014
Dako is Official Platinum Sponsor of Global Pathology Congress for Second Straight YearMar 03, 2014
Dako further expands world’s leading special stain solution for cancer diagnosticsFeb 28, 2014
New Study Reinforces Major Advantages of Dako’s HER2 IQFISH pharmDx™ in Breast Cancer DiagnosticsFeb 14, 2014
Dako and Amgen expand collaborationFeb 11, 2014
Dako to collaborate with Merck on development of companion diagnostics for cancer treatmentJan 09, 2014

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.

Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement

Get in Touch with Dako in Poland

Contact Us Directly
+48 58 661 1879
+48 58 661 3390

Pathology Products, Flow Cytometry Products and Specific Proteins
Dako Polska Sp. z o.o.

ul. Swietojanska 134
81-404 Gdynia

Detailed contact information

Submit an Inquiry

How would you like us to follow up?

Your session expired

You have been logged out. Log in again to retrieve your Cart.